HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John P Stein Selected Research

Transitional Cell Carcinoma

11/2009Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
9/2009Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer.
5/2009Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
2/2009Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience.
2/2009The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer.
4/2008Urethral recurrence in a woman after continent orthotopic urinary diversion for bladder cancer.
9/2007Open radical cystectomy with lymphadenectomy remains the treatment of choice for invasive bladder cancer.
6/2007Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
5/2007The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer.
4/2007Superficial bladder cancer: part 2. Management.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John P Stein Research Topics

Disease

48Urinary Bladder Neoplasms (Bladder Cancer)
02/2013 - 06/2002
33Neoplasms (Cancer)
02/2013 - 07/2003
24Transitional Cell Carcinoma
11/2009 - 07/2003
8Carcinoma (Carcinomatosis)
06/2015 - 09/2003
7Prostatic Neoplasms (Prostate Cancer)
09/2011 - 12/2004
7Lymphatic Metastasis
11/2009 - 07/2003
3Neoplasm Metastasis (Metastasis)
02/2009 - 06/2006
2Disease Progression
05/2009 - 12/2004
2Margins of Excision
02/2009 - 09/2007
2Carcinoma in Situ
01/2006 - 04/2005
2Adenocarcinoma
07/2005 - 05/2005
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
05/2005 - 02/2005
1Urinary Incontinence
11/2006
1Erectile Dysfunction
11/2006
1Seminoma
10/2005
1Small Cell Carcinoma
07/2005
1Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2005
1Large Cell Carcinoma
07/2005
1Lower Urinary Tract Symptoms
05/2005
1Hematuria
05/2005
1Residual Neoplasm
05/2005
1Abnormal Reflex (Hyperreflexia)
05/2005
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
05/2005
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
05/2005
1Overactive Urinary Bladder (Overactive Bladder)
05/2005
1Contracture
05/2005
1Teratoma (Teratoid Tumor)
02/2005
1Stress Urinary Incontinence
07/2004
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2002
1Ulcerative Colitis
03/2002

Drug/Important Bio-Agent (IBA)

3Biological ProductsIBA
06/2005 - 09/2004
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2013 - 04/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2011 - 02/2009
2Cisplatin (Platino)FDA LinkGeneric
09/2011 - 02/2009
2Vinblastine (Vinblastine Sulfate)FDA Link
09/2011 - 02/2009
2Methotrexate (Mexate)FDA LinkGeneric
09/2011 - 02/2009
2Prostate-Specific Antigen (Semenogelase)IBA
06/2006 - 12/2004
1Caspase 3 (Caspase-3)IBA
02/2013
1Apoptotic Protease-Activating Factor 1IBA
02/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2013
1Cadherins (E-Cadherin)IBA
02/2013
1GemcitabineFDA Link
02/2009
1A-factor (Streptomyces)IBA
01/2007
1AndrogensIBA
11/2006
1AntibodiesIBA
06/2006
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2006
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2006
1Docetaxel (Taxotere)FDA Link
04/2006
1Messenger RNA (mRNA)IBA
06/2005
1OligodeoxyribonucleotidesIBA
06/2005
1Small Interfering RNA (siRNA)IBA
06/2005
1EphB4 ReceptorIBA
06/2005
1Capsules (Microcapsules)IBA
05/2005
1SolutionsIBA
05/2005
1Telomerase (Telomerase Reverse Transcriptase)IBA
09/2004
1SurvivinIBA
09/2004
1Indicators and Reagents (Reagents)IBA
07/2003

Therapy/Procedure

49Cystectomy
06/2015 - 06/2002
26Lymph Node Excision (Lymph Node Dissection)
06/2015 - 07/2003
11Therapeutics
09/2011 - 08/2002
8Urinary Diversion (Ileal Conduit)
02/2009 - 04/2005
6Adjuvant Chemotherapy
09/2011 - 07/2003
6Drug Therapy (Chemotherapy)
09/2011 - 06/2002
5Prostatectomy (Retropubic Prostatectomy)
09/2011 - 12/2004
4Radiotherapy
11/2006 - 06/2002
3Contraindications
09/2007 - 07/2005
1Nephroureterectomy
06/2007
1Treatment Delay
11/2006
1Penile Prosthesis (Penile Implants)
11/2006
1Artificial Urinary Sphincter
11/2006
1Catheters
05/2005
1Restorative Proctocolectomy
03/2002
1Ileostomy
03/2002